The global prefilled syringes market share is projected to grow from US$ 6.69 Billion in 2022 to US$ 15.0 Billion by 2030, driven by the increasing prevalence of chronic diseases and rising demand for self-injection devices. The market is expected to grow at a CAGR of 10.6% during this period, with significant advancements in biologic drug delivery. North America currently leads the market, while Asia Pacific is expected to register the highest growth rate.US & Canada, March 28, 2025 (GLOBE NEWS